Nature's Sunshine Products Reports Receipt of Noncompliance Notice from Nasdaq

Nature's Sunshine Products Inc. (NASDAQ:NATRE) announced
today that, on March 21, 2006, it received notice from The Nasdaq
Stock Market that, because the Company's Annual Report on Form 10-K
for the fiscal year ended December 31, 2005 was not filed with the
Securities and Exchange Commission by March 16, 2006, the Company is
not in compliance with Marketplace Rule 4310(c)(14). As was previously
disclosed, the Company has not been in compliance with Nasdaq
Marketplace Rule 4310(c)(14) because it has not filed a complete
quarterly report on Form 10-Q for the quarter ended September 30,
2005. However, the Nasdaq Listing Qualifications Panel granted the
Company an extension until March 31, 2006 to file its complete Form
10-Q. The Company's delayed filing of its Form 10-K serves as an
additional basis for delisting the Company's common stock from the
Nasdaq National Market.
   The Company has previously disclosed in filings with the
Securities and Exchange Commission that, because of issues raised in
the Company's ongoing internal investigation, the Company does not
expect to be able to meet the March 31, 2006 10-Q filing deadline set
by the Panel for filing the Company's September 30, 2005 Form 10-Q nor
does the Company expect to file its annual report on Form 10-K for the
fiscal year ended December 31, 2005 on or before March 31, 2006. The
Company intends to consider seeking an extension to file both the Form
10-Q and the Form 10-K. However, no assurance can be made that the
Company will be granted any further extension and, therefore, the
Company's common stock may be subject to delisting from the Nasdaq
National Market. If the Company's common stock is delisted from the
Nasdaq National Market, the liquidity of its common stock would be
adversely impacted and the Company may experience other adverse
consequences resulting from the delisting and the failure to file
periodic reports.

   About Nature's Sunshine

   Nature's Sunshine Products manufactures and markets through direct
sales encapsulated and tableted herbal products, high quality natural
vitamins, and other complementary products. In addition to the United
States, the Company has operations in Japan, Mexico, Central America,
South Korea, Canada, Dominican Republic, Venezuela, Ecuador, Peru, the
United Kingdom and Ireland, Colombia, Brazil, Thailand, Israel,
Singapore and Taiwan. The Company also has exclusive distribution
agreements with selected companies in Argentina, Australia, Chile, New
Zealand, Norway, and the Russian Federation.
   Statements in this press release concerning the Company's request
to remain listed and its anticipated filing of periodic reports with
the Securities and Exchange Commission, together with other statements
that are not historical facts, are "forward-looking statements" as
that term is defined under Federal Securities Laws. "Forward-looking
statements" are subject to risks, uncertainties and other factors,
which could cause actual results to differ materially from those set
forth in such statements. Such risks, uncertainties, and factors
include, but are not limited to, the results of the Company's ongoing
internal investigation, the impact of the delisting of the Company's
common stock and failure to file periodic reports and foreign business
risks, as well as other risks detailed in the Company's filings with
the Securities and Exchange Commission. The Company disclaims any
obligations to update any forward-looking statement as a result of
developments occurring after the date of this press release.